The merger is seen as main consolidation within the sector because the entry of massive gamers like Reliance Industries and Amazon
API Holdings, the mum or dad entity of PharmEasy will purchase 100% fairness shares of Medlife
Just lately, Reliance Retail entered the web drugs supply area by buying 60% fairness stake in epharmacy startup Netmeds

The Competitors Fee of India (CCI), on Tuesday (September 22), accredited the merger of on-line pharmacy Medlife with PharmEasy, the primary main consolidation within the sector because the entry of massive gamers like Reliance Industries and Amazon.
The deal will see API Holdings, the mum or dad entity of PharmEasy, purchase 100% fairness shares of Medlife, filings with the CCI present. Medlife’s promoters will in return get a 19.95% stake within the mixed entity.
Launched in 2015, PharmEasy provides companies together with on-line medicines, healthcare merchandise and reserving lab checks in additional than 1000 cities. It has up to now raised $328 Mn throughout seven funding rounds and had final raised $220 Mn in November 2019. PharmEasy, which counts Temasek, Bessemer Enterprise Companions, Nandan Nilekani and so on., amongst its buyers, was final valued at reportedly $700 Mn. Alternatively, Medlife was based in 2014 serving over 4,000 cities, with about $56.5 Mn being raised thus far.
Medlife and PharmEasy sought CCI approval on the merger final month. Although different transactional particulars of the potential merger haven’t been revealed, media experiences recommend that it could lead on as much as $200 Mn to $250 Mn and will worth the mixed entity at round $1 Bn. Just lately, the South Chemist and Distributors Affiliation (SCDA) wrote to the Competitors Fee of India (CCI) claiming that the web gross sales of medicines will not be authorized beneath the Indian regulation, subsequently the merger ought to be rejected.
They’d added that there have been already particular pointers on the gross sales and distribution of pharmaceutical medicines and medicines, which don’t point out epharmacies or on-line gross sales. These legal guidelines embrace Medicine and Cosmetics Act of 1940, Medicine and Cosmetics Guidelines of 1945, Pharmacy Act of 1948, Pharmacy Follow Laws of 2015, Indian Medical Act of 1956 and Code of Ethics Laws of 2002, and Medicine and Magic Cures (Objectionable Commercial) Act of 1954.
The merger comes at a time when giants like Reliance Retail, Amazon have entered the pharmacy area together with Flipkart planning a foray too.
After months of hypothesis, Reliance Retail entered the web drugs supply area by buying 60% fairness stake in epharmacy startup Netmeds, formally referred to as Vitalic Well being Personal Restricted, for INR 620 Cr ($83 Mn).
With the acquisition, the Mukesh Ambani-led firm has received the 100% fairness possession of Netmeds subsidiaries — Tresara Well being Pvt Ltd, Netmeds Market Ltd and Dadha Pharma Distribution Personal Restricted. All these subsidiaries are collectively referred to as Netmeds, and are within the enterprise of pharma distribution and gross sales, and enterprise help companies.